Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




3D Printing Used to Create Degradable Microfluidic Devices

By LabMedica International staff writers
Posted on 21 Sep 2017
A team of bioengineers modified the stereolithographic three-dimensional printing technique to create a series of microfluidic devices from biocompatible and degradable materials.

The stereolithographic technique is based on a computer-guided ultraviolet laser that traces patterns across the surface of a photoactive polymer solution. More...
The light causes the polymers to coalesce, forming covalently bound, solid three-dimensional structures within the solution. The tracing process is repeated until an entire object is built from the bottom up.

Investigators at Brown University (Providence, RI, USA) modified this technique by printing on hydrogels using noncovalent (ionic) crosslinking, which enabled reversible patterning with controlled degradation. They demonstrated the feasibility of this approach using sodium alginate, photoacid generators, and various combinations of divalent cation salts, which could be used to tune the hydrogel degradation kinetics, pattern fidelity, and mechanical properties.

The investigators described in the September 5, 2017, online edition of the journal Lab on a Chip how they used this technique to prepare template perfusable microfluidic channels within a second encapsulating hydrogel for T-junction and gradient devices. Degradable alginate barriers were used to direct collective cell migration from different initial geometries, revealing differences in front speed and leader cell formation. The presence and degradation of printed alginate microstructures were further verified to have minimal toxicity on epithelial cells.

"The idea is that the attachments between polymers should come apart when the ions are removed, which we can do by adding a chelating agent that grabs all the ions," said senior author Dr. Ian Wong, assistant professor of engineering at Brown University. "This way we can pattern transient structures that dissolve away when we want them to. We can start to think about using this in artificial tissues where you might want channels running through it that mimic blood vessels. We could potentially template that vasculature using alginate and then dissolve it away like we did for the microfluidic channels."

Related Links:
Brown University


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Human Estradiol Assay
Human Estradiol CLIA Kit
Automated MALDI-TOF MS System
EXS 3000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.